New cancer clinical trial: The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slow-progressed Non-Small Cell Lung Cancer (NSCLC)

Published on: January 21, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share